micro News and Research

RSS
Glycogen synthase kinase-3 inhibitors found to attenuate COVID-19-associated cytokine storm

Glycogen synthase kinase-3 inhibitors found to attenuate COVID-19-associated cytokine storm

21 Mar 2022
Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

20 Mar 2022
World Sleep Day: Diagnosing chronic respiratory diseases from within the bedroom

World Sleep Day: Diagnosing chronic respiratory diseases from within the bedroom

18 Mar 2022
Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

17 Mar 2022
Researchers develop extraction-free saliva RT-LAMP assay for workplace surveillance of SARS-CoV-2

Researchers develop extraction-free saliva RT-LAMP assay for workplace surveillance of SARS-CoV-2

17 Mar 2022
Research finds link between long-term exposure to air pollution and autoimmune disease risk

Research finds link between long-term exposure to air pollution and autoimmune disease risk

16 Mar 2022
INTEGRA’s VIAFLO 384 proves indispensable in neurodegeneration research

INTEGRA’s VIAFLO 384 proves indispensable in neurodegeneration research

From INTEGRA Biosciences 16 Mar 2022
How capable are children to self-swab for SARS-CoV-2?

How capable are children to self-swab for SARS-CoV-2?

15 Mar 2022
People living near green spaces have 16% less stroke risk

People living near green spaces have 16% less stroke risk

15 Mar 2022
Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

14 Mar 2022
Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

14 Mar 2022
In silico screening of natural ACE2 inhibitors

In silico screening of natural ACE2 inhibitors

14 Mar 2022
Study indicates a 100 µg mRNA-1273 booster has acceptable safety and robust antibody response against SARS-CoV-2

Study indicates a 100 µg mRNA-1273 booster has acceptable safety and robust antibody response against SARS-CoV-2

11 Mar 2022
Updated results from ongoing study on the effect of a BNT162b2 booster dose on anti-SARS-CoV-2 antibodies

Updated results from ongoing study on the effect of a BNT162b2 booster dose on anti-SARS-CoV-2 antibodies

11 Mar 2022
Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

11 Mar 2022
Further optimization of cysteine-reactive pyrazoline-based covalent inhibitors for the SARS-CoV-2 Mpro

Further optimization of cysteine-reactive pyrazoline-based covalent inhibitors for the SARS-CoV-2 Mpro

11 Mar 2022
Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

10 Mar 2022
Mushroom-derived compounds have potential for use as COVID-19 therapeutic

Mushroom-derived compounds have potential for use as COVID-19 therapeutic

9 Mar 2022
Effect of COVID-19 mRNA vaccine on in vitro glial cells of the brain studied by Raman spectroscopy and imaging

Effect of COVID-19 mRNA vaccine on in vitro glial cells of the brain studied by Raman spectroscopy and imaging

8 Mar 2022
Identification of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding

Identification of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding

7 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback